MICHELLE KELLY: Open Payments
NPI 1255605135 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 48 payments from 18 companies in 2025. Trend: 2023 $581 · 2024 $656 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $255 |
| Alnylam Pharmaceuticals Inc. | 4 | $182 |
| Novo Nordisk Inc | 4 | $166 |
| HEARTFLOW, INC. | 1 | $129 |
| Gilead Sciences, Inc. | 1 | $117 |
| Merck Sharp & Dohme LLC | 5 | $106 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $100 |
| Baxter Healthcare | 3 | $69 |
| Kestra Medical Technology Services, Inc. | 2 | $67 |
| Amgen Inc. | 3 | $48 |
Products named: Wegovy, FFRct, AIRSUPRA, AMVUTTRA, Descovy, VERQUVO, LifeVest, FARXIGA.
Industry payments across PA — which companies pay providers there.
